학술논문
Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Statin-Treated Subjects With Hypercholesterolemia
Document Type
Article
Author
Source
In The American Journal of Cardiology 1 May 2015 115(9):1212-1221
Subject
Language
ISSN
0002-9149